Delhi High Court rules overseas payments not automatically taxable, grants ₹783 crore refund to Teva
The Delhi High Court decided that payments from Indian firms to foreign entities are not automatically subject to Indian tax, ordering a refund of about ₹783 crore to Teva Israel.
A bench of the Delhi High Court ruled on September 15 that payments made by Indian companies to overseas parties are not automatically taxable in India, granting Teva Israel a refund of about ₹783 crore plus interest. The dispute involved Ranbaxy Laboratories, now merged with Sun Pharmaceutical Industries, which had paid Teva Israel under a 2011 settlement linked to the U.S. launch of generic atorvastatin. The court found that the income was connected to U.S. regulatory and market activities, not to India, and said the tax department must show a clear nexus before taxing such receipts.
It also rebuked the Authority for Advance Rulings for overstepping its jurisdiction by probing commercial motives. Tax experts say the decision could affect many multinational firms in sectors such as technology and telecommunications. The ruling underscores that India cannot levy tax merely because a payment originates from an Indian resident.
Why it matters
The ruling clarifies India's limits on taxing foreign income, impacting multinational companies' tax obligations.
In this story
